Table 3.
HPV single infection and its association with cervical lesion grade
| HPV genotype | LSIL | HSIL | SCC | ||||||
|---|---|---|---|---|---|---|---|---|---|
| p | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | |
| HPV 16 | Reference | 0.001 | 1.74 | 1.26–2.39 | 0.007 | 3.21 | 1.37–7.51 | ||
| HPV 18 | Reference | 0.652 | 1.18 | 0.57–2.46 | 0.014 | 4.78 | 1.38–16.62 | ||
| HPV 31 | Reference | 0.010 | 6.54 | 1.56–27.51 | - | 0.00 | 0 - . | ||
| HPV 45 | Reference | 0.521 | 0.78 | 0.36–1.68 | 0.971 | 1.04 | 0.13–8.48 | ||
| HPV 58 | Reference | 0.485 | 1.36 | 0.58–3.19 | - | 0.00 | 0 - . | ||
| HR-HPV | Reference | 0.006 | 0.54 | 0.35–0.84 | 0.682 | 0.77 | 0.22–2.70 | ||
| LR-HPV | Reference | 0.492 | 0.72 | 0.28–1.83 | - | 0.00 | 0 - . | ||
Values in bold = p < 0.05; OR:Odd ratio; CI Confidence Interval
HPV Human papillomavirus, LSIL Low-grade squamous intraepithelial lesions, HSIL High-grade squamous intraepithelial lesions, SCC Squamous Cervical Carcinoma
HR-HPV High-risk-human papillomavirus, infection by HPV 26, 33, 35, 39, 51, 52, 53, 56, 59, 66 or 68
LR-HPV Low-risk-human papillomavirus, infections by HPV including 6, 11, 42, 44, 55, 70, 72, 81 or 83